Company intelligence
Seagrove Partners
About Seagrove Partners
Seagrove Partners is a full-service Market Research consultancy, exclusively serving the healthcare industry. Our associates have over 75 years of combined executive-level experience in the following healthcare areas: Pharmaceuticals, Medical Devices, Diagnostics, Healthcare Providers, Managed Care Organizations, and Equity Research. Therapeutic focus areas include: Cardiovascular/Metabolic, Inflammatory Diseases/Immunology, and Central Nervous System disorders. We have extensive experience in helping clients conduct research for new product planning, launch preparation, equity fund raising, and commercialization of approved products. Through our Payer Portal, we also connect pharma, device and diagnostic companies with an extensive network of formulary decision makers in the managed care community. We are committed to improving the human condition through research.
Verified activity
Signals from Seagrove Partners
2 published signals
Research & Knowledge
Seagrove Partners published the 2026 Oncology Blue Book, featuring ten tumor types, 325 slides, a syndicated view of the oncology market, and a rebuilt version of the oncology market report from 2025 to 2040.
Reported by Erik Verhoef
Research & Knowledge
Seagrove Partners released the Q2 2026 edition of the SeaTRAK Oncology Tracker, featuring key oncology developments including Keytruda, J&J's myeloma franchise, AstraZeneca, Merck and Moderna's individualized mRNA therapy, Zenbexus and mezigdomide, Roche's divarasib, and two antibody-drug conjugate classes failing in lung cancer.
Reported by Erik Verhoef